Cann Group set for ‘stronger future’ after ‘challenging period’, outgoing chair tells shareholders by Steve Jones December 4, 2025February 21, 2026 Departing Cann Group chairman Doug Rathbone has told shareholders the company is preparing for a “far […]
AMCA chair delivers impassioned defence of medicinal cannabis amid regulatory reform threat by Steve Jones December 4, 2025December 4, 2025
‘Totally disproportionate’: Welsh to appeal after prescribing ban upheld by Adam Sheldon December 4, 2025December 4, 2025
Altum calls on prescribers to ‘back compliant firms’ after losses double by Steve Jones December 3, 2025December 4, 2025
AP approvals fall as medicinal cannabis sales plateau, Penington report finds by Adam Sheldon December 3, 2025December 4, 2025
Cannim gets stay of execution as potential buyer moves in by Steve Jones December 3, 2025December 4, 2025
Elixinol names new chair in pursuit of ‘sustainable and profitable business’ by Steve Jones December 2, 2025February 21, 2026
Chinese investor behind Y Cannabis poised to take full control of Tasmanian Botanics in A$31m deal by Adam Sheldon December 2, 2025December 4, 2025
News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing by Adam Sheldon December 2, 2025February 21, 2026
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
